Trial intelligence / Profile preview

Propofol-based Total Intravenous Anesthesia vs Desflurane Anesthesia on NK Cell Activity After Hepatic Resection in Hepatocellular Carcinoma

TCTR20210218001Phase 2Completed

Sponsor
Chulalongkorn University
Start
Oct 2019
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of propofol, desflurane in hepatocellular carcinoma (HCC), sponsored by Chulalongkorn University. Started Oct 2019; status: completed.

02

Drugs

propofoldesflurane
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on TCTR20210218001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210218001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call